You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

induction maintenance

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Frontal Cortical Electroencephalographic Signal During

Not yet recruiting
  • Anesthesia
    • Colombes, France
      Hopital Louis Mourier
    Aug 30, 2023

    Hemodynamics, Postoperative Recovery, Anesthesia Trial (propofol, ciprofol)

    Not yet recruiting
    • Hemodynamics
    • +2 more
    • (no location specified)
    Dec 17, 2022

    Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Wuhan, Hubei, China
      Institute of Hematology, Union Hospital, Tongji Medical College,
    Nov 18, 2023

    Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

    Completed
    • Lymphoid Leukemia
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Jan 30, 2023

    Lymphomas Non-Hodgkin's B-Cell Trial in Ballarat, Box Hill, Heidelberg (Avelumab)

    Active, not recruiting
    • Lymphomas Non-Hodgkin's B-Cell
    • Ballarat, Victoria, Australia
    • +2 more
    Jan 30, 2023

    Small Cell Lung Carcinoma Trial in Milano (Cyclic, 5-day calorie restriction, Atezolizumab)

    Not yet recruiting
    • Small Cell Lung Carcinoma
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale Tumori
    Jan 19, 2023

    Progression Free Survival, Overall Survival, Maintenance Trial (Ixazomib DX/Lenalidomide DX)

    Not yet recruiting
    • Progression Free Survival
    • +2 more
    • Ixazomib DX/Lenalidomide DX
    • (no location specified)
    Jul 27, 2022

    Lung Cancer, Non-small Cell Trial in Nanjing (hypofractionated radiation therapy)

    Active, not recruiting
    • Lung Cancer, Non-small Cell
    • hypofractionated radiation therapy
    • Nanjing, Jiangsu, China
      Jiangsu Cancer Hospital
    Mar 13, 2023

    Metastatic Breast Cancer Trial (Inavolisib, Phesgo, Placebo)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Jun 7, 2023

    Acute Myeloid Leukemia Trial in Aurora (Azacitidine and Venetoclax)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Azacitidine and Venetoclax
    • Aurora, Colorado
      University of Colorado Denver
    Aug 1, 2022

    Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)

    Recruiting
    • Mantle Cell Lymphoma
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Sep 13, 2022

    Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)

    Recruiting
    • Giant Cell Arteritis
    • Bonn, Germany
      Medical Clinic and Polyclinic III Internal medicine Oncology, He
    Dec 16, 2022

    Cancer of Pancreas Trial in Cairo (Capecitabine, follow up)

    Recruiting
    • Cancer of Pancreas
    • Cairo, Egypt
    • +2 more
    Sep 30, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Brescia (Niraparib)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Brescia, Italy
      Asst Degli Spedali Civili Di Brescia
    Aug 3, 2022

    Metastatic Colorectal Cancer Trial (Niraparib)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • (no location specified)
    Jun 7, 2022

    Metastatic Squamous Non-Small Cell Lung Carcinoma Trial in Chicago (Cabozantinib 40 MG, Pembrolizumab 200mg)

    Recruiting
    • Metastatic Squamous Non-Small Cell Lung Carcinoma
    • Cabozantinib 40 MG
    • Pembrolizumab 200mg
    • Chicago, Illinois
      University of Illinois at Chicago
    Jan 20, 2023

    Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)

    Not yet recruiting
    • Renal Transplant Rejection
    • Induction Therapy
    • (no location specified)
    Sep 22, 2022

    Triple Negative Breast Cancer Trial in Shanghai (Cisplatin, Nab-paclitaxel, Pembrolizumab)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Apr 18, 2022

    Lymphoblastic Leukemia in Children Trial (induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal

    Not yet recruiting
    • Lymphoblastic Leukemia in Children
    • induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
    • +7 more
    • (no location specified)
    Oct 24, 2023

    Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)

    Active, not recruiting
    • Chronic Lymphocytic Leucemia
    • Cologne, Germany
      German CLL Study Group
    Sep 14, 2022

    Prostate Cancer Aggressiveness, Prostate Carcinoma Trial in Houston (Cabazitaxel, Carboplatin, Prednisone 5Mg)

    Active, not recruiting
    • Prostate Cancer Aggressiveness
    • Prostate Carcinoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 5, 2022

    Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

    Not yet recruiting
    • Multiple Myeloma
    • Dara-VRd intensification, Dara-R maintenance
    • +4 more
    • (no location specified)
    Dec 13, 2022

    Multiple Myeloma Trial in Seoul (Lenalidomide maintenance)

    Recruiting
    • Multiple Myeloma
    • Lenalidomide maintenance
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Aug 10, 2022

    Crohn's Disease Trial (Risankizumab)

    Not yet recruiting
    • Crohn's Disease
    • (no location specified)
    Aug 10, 2023

    Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)

    Recruiting
    • Idiopathic Pulmonary Hemosiderosis
    • Leflunomide
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Jun 30, 2023